- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-1182
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Inhibition of γ-Secretase Leads to an Increase in Presenilin-1 ; day:16 ; month:8 ; year:2017 ; pages:1-12
Molecular neurobiology ; (16.8.2017), 1-12
- Keyword
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Creator
-
Sogorb-Esteve, Aitana
- Contributor
-
García-Ayllón, María-Salud
Llansola, Marta
Felipo, Vicente
Blennow, Kaj
Sáez-Valero, Javier
SpringerLink (Online service)
- DOI
-
10.1007/s12035-017-0705-1
- URN
-
urn:nbn:de:1111-2017102916336
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sogorb-Esteve, Aitana
- García-Ayllón, María-Salud
- Llansola, Marta
- Felipo, Vicente
- Blennow, Kaj
- Sáez-Valero, Javier
- SpringerLink (Online service)
Other Objects (12)
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement
Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement
Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement
Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Fluid biomarkers in Alzheimer’s disease – current concepts